Loading insider details...
Beta
Latest Form 4 (Jun 10, 2026): Tax Withholding of 3,964 EBS shares, $31.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 3,964 | $31.7K |
| May 1, 2026 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 162,680 | n/a |
| Mar 6, 2026 | Emergent BioSolutions Inc. (EBS) | Expiration (Long) | 19,963 | n/a |
| Mar 6, 2026 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 23,650 | $199.6K |
| Mar 3, 2026 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 683 | $5.6K |
| Feb 11, 2026 | Emergent BioSolutions Inc. (EBS) | Disposition to Issuer | 46,155 | $504.0K |
| Jan 5, 2026 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 90,000 | n/a |
| Oct 17, 2025 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 4,995 | $48.0K |
| Jun 10, 2025 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 2,733 | $18.1K |
| Mar 10, 2025 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 146,888 | n/a |